Cirrosis hepática o falla hepática crónica agudizada: definición y clasificación
Cirrhosis or acute-on-chronic liver failure: definition and classification
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Mostrar biografía de los autores
La cirrosis se considera el estadio crónico e irreversible de la lesión hepática. Su etiología es diversa y abarca causas como las infecciones víricas, tóxicos como el alcohol, medicamentos, patologías autoinmunes y otras. La descompensación de la cirrosis hepática es consecuencia de cambios fisiopatológicos que se dan con el tiempo como ascitis, peritonitis bacteriana espontánea, hemorragia del tubo digestivo, síndrome hepatorrenal, encefalopatía hepática o hipertensión portopulmonar, mientras que la falla hepática crónica agudizada debe considerarse como una entidad que debe diferenciarse de la anterior, ya que es una falla multiorgánica de curso rápido, por lo regular en pacientes hospitalizados en unidad de cuidado intensivo, a menudo secundaria a desencadenantes como estados de choque. El clínico debe identificarlas para su abordaje y evaluación. El método actual adecuado para estadificar esta entidad es el puntaje CLIFF SOFA, que evalúa la mortalidad a 28 y 90 días, permitiendo intervenciones adecuadas en cada caso.
Visitas del artículo 26032 | Visitas PDF 40087
Descargas
- Lefton H, Rosa A, Cohen M. Diagnosis and Epidemiology of Cirrhosis. Med Clin N Am. 2009;93(4):787-99, vii. doi: 10.1016/j.mcna.2009.03.002
- Tsochatzis EA, Bosch J, Burroughs JK. Liver cirrhosis. Lancet. 2014;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5
- Fleming K, Aithal G, Solaymani-Dodaran M, Card T, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: A general population-based study. J Hepatol. 2008;49(5):732-8. doi: 10.1016/j.jhep.2008.05.023
- Kamath P, Shah V. Overview of Cirrhosis In: Feldman V, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11 ed. Philadelphia: Elsevier; 2016. p. 1254-60.e1
- Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360(26):2758-69. doi: 10.1056/NEJMra0805786
- McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 1989;9(3):349-51. doi: 10.1002/hep.1840090302
- Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012;56(1):255-66. doi: 10.1016/j.jhep.2011.06.010.
- Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology. 2011;53(2):517-26. doi: 10.1002/hep.24080
- Páramo Hernández D, Otero Regino W, Pineda Ovalle L. Fibrogénesis hepática. Rev Col Gastroenterol. 2010;25(2):187– 97
- Pinzani M, Rosselli M, Zuckermann M, Liver Cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25(2):281-290. doi: 10.1016/j.bpg.2011.02.009
- Bosch J, Garcia-Pagrin JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol. 2000;32(1 Suppl):141-56. doi: 10.1016/s0168-8278(00)80422-
- Rockey D. Hepatic Fibrosis and Cirrhosis. In: McManus LM, Mitchell RN, editors. Pathobiology of Human Disease: a dynamic encyclopedia of disease mechanisms Elsevier; 2014. p. 1809–16.
- Bird TG, Ramachandran P, Thomson E. Decompensated liver cirrhosis. Anaesthesia and Intensive Care Medicine. 2015;16(4):180–185. https://doi.org/10.1016/j.mpaic.2015.01.012
- Soublett, J, Páez M, Aldana L. Cirrosis Hepática: características de la peritonitis bacteriana espontánea. Gen. 2017;71(2):68-73.
- A Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol. 2000;32(1 Suppl):157-70. doi: 10.1016/s0168-8278(00)80423-7
- Villanueva Bendek, I. (2004). Síndrome hepatorrenal: Revisión de la literatura y análisis crítico de los criterios diagnósticos. Rev Col Gastroenterol. 2004;19(3):195-204.
- Erly B, Carey WD, Kapoor B, McKinney JM, Tam M, Wang W. Hepatorenal syndrome: a review of pathophysiology and current treatment options. Semin Intervent Radiol. 2015;32(4):445-54. doi: 10.1055/s-0035-1564794
- Venkat D, Venkat KK. Hepatorenal syndrome. South Med J. 2010;103(7):654-661. doi: 10.1097/SMJ.0b013e3181e07751
- Belcher JM, Parikh CR, Garcia–Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol. 2013;11(12):1550-8. doi: 10.1016/j.cgh.2013.03.018
- McCormick PA, Donnelly C. Management of hepatorenal syndrome. Pharmacol Ther. 2008;119(1):1-6. doi: 10.1016/j.pharmthera.2008.02.012
- Márquez-Aguirre AL, Canales-Aguirre AA, Gómez-Pinedo U, Gálvez-Gastélum FJ. Aspectos moleculares de la encefalopatía hepática. Neurología. 20102;5(4): 239-247. doi: 10.1016/j.nrl.2009.12.001
- Butterworth R. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000;32(1 Suppl):171-80. doi: 10.1016/s0168-8278(00)80424-9
- Butterworth R Hepatic encephalopathy in alcoholic cirrhosis. Handb Clin Neurol. 2014;125:589-602. doi: 10.1016/B978-0-444-62619-6.00034-3
- Aguilar Reina J. Encefalopatía hepática. Medicine. 2022;11(11):652-659. doi: 10.1016/S0304-5412(12)70362-1
- Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716-21. doi: 10.1053/jhep.2002.31250
- Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology. 2000;32(4 Pt 1):859-65. doi: 10.1053/jhep.2000.7519
- Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-chronic liver failure: an update. Gut. 2017;66(3):541-553. doi: 10.1136/gutjnl-2016-312670
- Figueiredo A, Romero-Bermejo F, Perdigoto R, Marcelino P. The end-organ impairment in liver cirrhosis: appointments for critical care. Crit Care Res Pract. 2012;2012:539412. doi: 10.1155/2012/539412
- Pudil R, Pelouch R, Praus R., Vašatová M, Hůlek P. Heart failure in patients with liver cirrhosis. Cor et Vasa. 2013;55(4):e391-e396. https://doi.org/10.1016/j.crvasa.2013.06.002
- Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq N, Ihimoyan A. Systemic vascular resistance in cirrhosis: a predictor of severity?. Hepat Med. 2014;6:95-101. doi: 10.2147/HMER.S67036
- Poordad FF. Presentation and complications associated with cirrhosis of the liver. Curr Med Res Opin. 2015;31(5):925-37. doi: 10.1185/03007995.2015.1021905
- Garcia‐Tsao G, Parikh CR, Viola A.. Acute kidney injury in cirrhosis. Hepatology. 2008;48(6):2064-2077. doi: 10.1002/hep.22605
- Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, Jalan R. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology, 2007;6(3):831-840. doi: 10.1002/hep.21737
- Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61(2):396-407. doi: 10.1016/j.jhep.2014.04.012
- Abdel-Khalek E, El-Fakhry A, Helaly M, Hamed M, Elbaz O. Systemic inflammatory response syndrome in patients with liver cirrhosis. Arab J Gastroenterol. 2011;12(4):173-177. doi: 10.1016/j.ajg.2011.11.006
- Ferreira FL, Bota DP, Bross A, Melot C. Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-8. doi: 10.1001/jama.286.14.1754
- Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Gerbes A. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-1437. doi: 10.1053/j.gastro.2013.02.042
- Durand, F, Valla D. Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD. J Hepatol. 2005;42 Suppl(1):S100-7. doi: 10.1016/j.jhep.2004.11.01
- Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl. 2003;9(2):117-23. doi: 10.1053/jlts.2003.50027
- Duan BW, Lu SC, Wang ML, Liu JN, Chi P, Lai W, et al. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases. J Surg Res. 2013;183(2):936-943. doi: 10.1016/j.jss.2013.03.008
- Ravindra BS, Surude R, Srinivas MG, Deviprasad S, Samarth A, Sawant, P. Comparison of CHILD, MELD and MELD-Na in Predicting Survival in Patients with Cirrhosis of Liver. Journal of Clinical and Experimental Hepatology. 2011:1(1):17. doi: 10.1016/S0973-6883(11)60037-6
- Cooper GS, Bellamy P. Dawson NV, Desbiens N, Jr Fulkerson WJ, Goldman L, Landefeld CS. A prognostic model for patients with end-stage liver disease. Gastroenterology. 1997;113(4):1278-88. doi: 10.1053/gast.1997.v113.pm9322523
- Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Hopf C. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038-47. doi: 10.1016/j.jhep.2014.06.012
- Stravitz RT. Acute-on-chronic liver failure—no longer an entity without definition. Nat. Rev. Gastroenterol. Hepatol. 2014;11:580–581. https://doi.org/10.1038/nrgastro.2014.161
- Barosa R, Roque-Ramos L, Patita M, Nunes G, Fonseca J. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward. Rev. Esp. Enferm. Dig. 2017;109(6): 399-405. https://dx.doi.org/10.17235/reed.2017.4701/2016
- Cavallazzi R, Awe O, Vasu T, Hirani A, Vaid U, Leiby B, Kraft W , Kane G Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis. Crit Care. 2012;27(4):424.e1-6. doi: 10.1016/j.jcrc.2011.11.014
- Morimoto N, Okada K, Okita Y. The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis. Ann Thorac Surg. 2013;96(5):1672–8. doi: 10.1016/j.athoracsur.2013.06.007
- Lucidi V, Gusto T, Moreno C, Donckier V. Liver transplantation in the context of organ shortage: toward extension and restriction of indications considering recent clinical data and ethical framework. Curr Opin Crit Care. 2015;21(2):163–170. doi: 10.1097/MCC.0000000000000186
- Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland-Fischer P, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol. 2015;62(4):831-40. doi: 10.1016/j.jhep.2014.11.012